StonvexLoading…
StonvexStonvexStonvexCore line items from UXIN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $463.27M | $204.84M | $190.40M | $299.85M |
Operating Income | $-24.82M | $-23.91M | $-43.28M | $-51.97M |
Net Income | $-37.53M | $-27.31M | $-51.58M | $-19.97M |
EPS (Diluted) | $0.00 | $0.00 | $-0.15 | $-0.66 |
Total Assets | $345.88M | $267.41M | $289.20M | $104.64M |
Total Liabilities | $330.84M | $296.63M | $309.02M | $188.78M |
Cash & Equivalents | $11.87M | $3.44M | $3.23M | $13.50M |
Free Cash Flow OCF − CapEx | $-75.19M | $-27.28M | $-38.11M | $-41.40M |
Shares Outstanding | 62.76B | 56.74B | 2.19B | 1.34B |